The need for conducting randomized trials in a pandemic to provide high quality evidence: overcoming the challenges by Conly, J

Sars-Cov-2 exposures of healthcare workers and acquisition of COVID-19 by Leal, J, Jefferson, T, Conly, J

Can the application of the international health regulations to antimicrobial resistance events help to preserve antimicrobials? by Wernli D, Haustein T, Conly J, Harbarth S

The Pandemic EVIDENCE Collaboration - Recruitment of Evidence-Informed Fellows by Heneghan, C, Davis, R, Conly, J

Annual report prepared for McCall MacBain Foundation: the Pandemic EVIDENCE Collaboration: September 2023 – August 2024 by Conly, J, Davis, R, Heneghan, C

Other Authors: “…Conly, J…”

The Pandemic EVIDENCE Collaboration programme launch - meeting agenda by Davis, R, Conly, J, Heneghan, C

Field evaluation (FE) of the World Health Organization (WHO) interim guidelines (IG) on infection prevention and control (IPC) of epidemic and pandemic-prone acute respiratory dise... by Conly J, Thakur R, Eremin S, Silva C

The Pandemic EVIDENCE Collaboration Pillar 1: diagnostics and transmission by Conly, J, Plüddemann, A, Jefferson, T, Rosca, C, Heneghan, C

Reporting surgical site infections (SSIs) using different surveillance systems— complexity of infection matters by Ellison, J, Chakravorty, D, Conly, J, Kim, J, Litvinchuk, S, Pokhrel, A, Shen, Y, Smith, C, Bush, K

Non-pharmacological interventions: nomenclature, taxonomy, and a working definition by Conly, J, Aronson, JK, Plüddemann, A, Stelfox, T, Onakpoya, I, Gandini, S, Loeb, M, Rosca, C, Jefferson, T, Fiest, K, Leal, J, Heneghan, C

Developing evidence-informed non-pharmacological interventions during public health emergencies by Conly, J, Stelfox, T, Heneghan, C, Plüddemann, A, Fiest, K, Haldane, V, Loeb, M, Richards, G, Glasziou, P, Fretheim, A, Jefferson, T, Onakpoya, I, Gandini, S, Maltoni, S, Rosca, C, Byambasuren, O, Bartoszko, J, Leal, J, Jones, M